Cite
Additional file 1: of MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinib
MLA
Young, Adelaide I. J., et al. Additional File 1: Of MCL-1 Inhibition Provides a New Way to Suppress Breast Cancer Metastasis and Increase Sensitivity to Dasatinib. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........8a3415b03912aea0e30797e7b6ecd585&authtype=sso&custid=ns315887. Accessed 19 Dec. 2024.
APA
Young, A. I. J., Law, A., Castillo, L., Chong, S., Cullen, H., Koehler, M., Herzog, S., Brummer, T., Erinna Lee, Fairlie, W., Morghan Lucas, Herrmann, D., Allam, A., Timpson, P., D. Watkins, Millar, E., OâToole, S., Gallego-Ortega, D., Ormandy, C., & Oakes, S. (n.d.). Additional file 1: of MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinib.
Chicago
Young, Adelaide I. J., Andrew Law, Lesley Castillo, Sabrina Chong, Hayley Cullen, Martin Koehler, Sebastian Herzog, et al. 2024. “Additional File 1: Of MCL-1 Inhibition Provides a New Way to Suppress Breast Cancer Metastasis and Increase Sensitivity to Dasatinib.” Accessed December 19. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........8a3415b03912aea0e30797e7b6ecd585&authtype=sso&custid=ns315887.